Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-009847

Ex Vice President of Research acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Huizinga Robert Bindert Ex Vice President of Research 2021-05-11 Option exercise +40,000 $3.02 $120,800 143,592 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Huizinga Robert Bindert Ex Vice President of Research 2021-05-11 Option exercise · Stock Option (right to buy) −40,000 0 D: show line 2 in the form
Loading xslF345X03/wf-form4_162076816300353.xml…